Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04064567 · ClinicalTrials.gov registry record · NA
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
A NA study of HIV/AIDS and Pre-exposure Prophylaxis, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 7
- Study locations
NCT04064567: Completed NA study of HIV/AIDS and Pre-exposure Prophylaxis, sponsored by University of Arkansas.
NCT04064567 is a NA study of HIV/AIDS and Pre-exposure Prophylaxis that has completed, run by University of Arkansas. The registered enrollment target is 100 participants, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 7 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04064567, a NA study of HIV/AIDS and Pre-exposure Prophylaxis, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 7
- Study locations
Study Summary
Our proposed study will: provide a novel exploration of facilitators and barriers to PrEP; allow us to target hard to reach populations, including men who have sex with men (MSM) and substance users (both of which are top funding priority groups for the National Institutes of Health) who experience intersecting markers of HIV risk; and inform regional, and possibly national, intervention approaches to combat the overlapping epidemic of HIV and incarceration.
Primary Outcome
The acceptability of the intervention will be determined with descriptive statistics of the participants' acceptability ratings, including whether they think the intervention is acceptable. Acceptability is defined as \> 80% of participants expressing high satisfaction with the intervention based on the Client Satisfaction Questionnaire - Revised (CSQ-8). The CSQ-8 is scored using a scale which ranges from 8-32, with a higher number indicating greater satisfaction.
Conditions Studied
Interventions
- OTHER Enhanced Standard of Care
- BEHAVIORAL PrEP-LINK
Study Locations (7)
Arkansas
- Better Community Development, Inc - Little Rock
- Central Arkansas Community Corrections Center - Little Rock
- Pulaski County County Regional Detention Facility - Little Rock
- Quality Living Center - Little Rock
- Recovery Centers of Arkansas - Little Rock
- Hidden Creek Opportunity Center - Little Rock
- East Central Arkansas Community Correction Center - West Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT04064567 record still lists
NCT04064567 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard of Care is the first listed.
NCT04064567 lists 7 locations in 1 state (Arkansas).
Frequently Asked Questions
What is clinical trial NCT04064567 about?
NCT04064567 is a clinical study titled "Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK". Our proposed study will: provide a novel exploration of facilitators and barriers to PrEP; allow us to target hard to reach populations, including men who have sex with men (MSM) and substance users (both of which are top funding priority groups for the National Institutes of Health) who experience ...
What is the current status of trial NCT04064567?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-09-30. Estimated completion is 2024-04-30.
What conditions does trial NCT04064567 study?
This clinical trial studies the following conditions: HIV/AIDS, Pre-exposure Prophylaxis.
What interventions are being tested in trial NCT04064567?
The interventions under investigation include: Enhanced Standard of Care (OTHER), PrEP-LINK (BEHAVIORAL).
Who is sponsoring clinical trial NCT04064567?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04064567 being conducted?
This trial has 7 study locations across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04064567's enrollment target sits among peer trials
100 35th of 61 higher than 25 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI